First Tracks Analyst Price Targets

Wall Street analyst price targets and consensus rating for First Tracks (TRAX).

Price Target Range — 3 Quarters

Analyst Consensus — 11 Analysts

11Buy

Consensus RatingOverweight# Analysts11Avg. Consensus PT$70Upside to Avg. PT+55.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 16, 2026	Leerink Partners	David Risinger	PT Raise	Outperform	$70→$90
Oct 13, 2026	Canaccord Genuity	Edward Nash	PT Raise	Buy	$50→$60
Oct 13, 2026	Evercore ISI Group	Gavin Clark-Gartner	PT Raise	Outperform	$65→$70
Oct 13, 2026	Wells Fargo	Derek Archila	PT Raise	Overweight	$62→$70
Sep 30, 2026	Canaccord Genuity	Edward Nash	Initiate	Buy	$50
Sep 18, 2026	Evercore ISI Group	Gavin Clark-Gartner	Initiate	Outperform	$65
Sep 16, 2026	Guggenheim	Yatin Suneja	Initiate	Buy	$100
Sep 3, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$57
Aug 13, 2026	Barclays	Etzer Darout	PT Raise	Overweight	$48→$65
Aug 13, 2026	Wedbush	Martin Fan	PT Raise	Outperform	$60→$70
Aug 13, 2026	Piper Sandler	Yasmeen Rahimi	PT Raise	Overweight	$54→$95
Aug 13, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$44→$57
Aug 10, 2026	UBS	Michael Yee	PT Raise	Buy	$45→$65
Jul 28, 2026	Wedbush	Martin Fan	PT Raise	Outperform	$30→$60
Jul 28, 2026	Wells Fargo	Derek Archila	PT Raise	Overweight	$30→$55
Jul 21, 2026	Barclays	Etzer Darout	PT Raise	Overweight	$40→$48
Jul 10, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$30→$44
Jul 8, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$30
Jun 8, 2026	Wells Fargo	Derek Archila	Initiate	Overweight	$30
May 4, 2026	Piper Sandler	Yasmeen Rahimi	Initiate	Overweight	$54

Analyst Ratings News

PRO
Leerink Partners Maintains Outperform on First Tracks, Raises Price Target to $90

Leerink Partners analyst David Risinger maintains First Tracks (NASDAQ:TRAX) with a Outperform and raises the price target from $70 to $90.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on First Tracks, Raises Price Target to $60

Canaccord Genuity analyst Edward Nash maintains First Tracks (NASDAQ:TRAX) with a Buy and raises the price target from $50 to $60.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on First Tracks, Raises Price Target to $70

Evercore ISI Group analyst Gavin Clark-Gartner maintains First Tracks (NASDAQ:TRAX) with a Outperform and raises the price target from $65 to $70.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on First Tracks, Raises Price Target to $70

Wells Fargo analyst Derek Archila maintains First Tracks (NASDAQ:TRAX) with a Overweight and raises the price target from $62 to $70.

Benzinga Newsdesk

PRO
Canaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

Canaccord Genuity analyst Edward Nash initiates coverage on First Tracks (NASDAQ:TRAX) with a Buy rating and announces Price Target of $50.

Benzinga Newsdesk

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts initiated bullish coverage on TRAX, BGSI, NPCE, CUE and NGVC, assigning Outperform/Buy ratings with price targets from $18 to $120.

Avi Kapoor

First Tracks Biotherapeutics Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

First Tracks Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Leerink Partners Maintains Outperform on First Tracks, Raises Price Target to $90

PRO
Canaccord Genuity Maintains Buy on First Tracks, Raises Price Target to $60

PRO
Evercore ISI Group Maintains Outperform on First Tracks, Raises Price Target to $70

PRO
Wells Fargo Maintains Overweight on First Tracks, Raises Price Target to $70

PRO
Canaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

People Also Watch

People Also Watch

First Tracks Biotherapeutics Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

First Tracks Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROLeerink Partners Maintains Outperform on First Tracks, Raises Price Target to $90

PROCanaccord Genuity Maintains Buy on First Tracks, Raises Price Target to $60

PROEvercore ISI Group Maintains Outperform on First Tracks, Raises Price Target to $70

PROWells Fargo Maintains Overweight on First Tracks, Raises Price Target to $70

PROCanaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

People Also Watch

People Also Watch

PRO
Leerink Partners Maintains Outperform on First Tracks, Raises Price Target to $90

PRO
Canaccord Genuity Maintains Buy on First Tracks, Raises Price Target to $60

PRO
Evercore ISI Group Maintains Outperform on First Tracks, Raises Price Target to $70

PRO
Wells Fargo Maintains Overweight on First Tracks, Raises Price Target to $70

PRO
Canaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50